X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5608) 5608
Publication (598) 598
Book Review (77) 77
Book Chapter (67) 67
Dissertation (10) 10
Government Document (6) 6
Conference Proceeding (5) 5
Magazine Article (4) 4
Book / eBook (2) 2
Paper (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3720) 3720
prostate cancer (3642) 3642
male (3579) 3579
index medicus (3216) 3216
androgen deprivation therapy (2406) 2406
oncology (2318) 2318
aged (1734) 1734
androgen-deprivation therapy (1731) 1731
urology & nephrology (1726) 1726
middle aged (1402) 1402
prostatic neoplasms - drug therapy (1397) 1397
cancer (1385) 1385
androgen deprivation (1277) 1277
prostatic neoplasms - pathology (1240) 1240
radical prostatectomy (1238) 1238
men (1196) 1196
radiotherapy (1182) 1182
care and treatment (1181) 1181
androgen antagonists - therapeutic use (1052) 1052
treatment outcome (827) 827
prostatic neoplasms - therapy (821) 821
aged, 80 and over (771) 771
prostatic neoplasms - radiotherapy (750) 750
risk factors (732) 732
survival (694) 694
radiation-therapy (689) 689
research (662) 662
androgens (657) 657
prostate (644) 644
prostate-specific antigen - blood (638) 638
health aspects (622) 622
carcinoma (612) 612
metastasis (609) 609
quality-of-life (606) 606
risk (550) 550
testosterone (543) 543
urology (533) 533
prostatic neoplasms - mortality (524) 524
prognosis (517) 517
antineoplastic agents, hormonal - therapeutic use (513) 513
analysis (509) 509
prostatectomy (499) 499
radiology, nuclear medicine & medical imaging (473) 473
prostatic neoplasms - blood (469) 469
prostatic neoplasms - surgery (469) 469
retrospective studies (451) 451
quality of life (446) 446
androgen antagonists - adverse effects (427) 427
mortality (420) 420
chemotherapy (418) 418
randomized controlled-trial (415) 415
neoplasm staging (408) 408
prostate-cancer (402) 402
endocrinology & metabolism (397) 397
therapy (395) 395
radiation therapy (391) 391
suppression (387) 387
osteoporosis (384) 384
castration (380) 380
medicine & public health (380) 380
article (377) 377
hematology, oncology and palliative medicine (373) 373
animals (362) 362
follow-up studies (355) 355
combined modality therapy (333) 333
prostatic neoplasms - metabolism (327) 327
disease-free survival (324) 324
prostate-specific antigen (324) 324
adult (323) 323
time factors (321) 321
patients (317) 317
brachytherapy (314) 314
disease progression (308) 308
external-beam radiotherapy (307) 307
zoledronic acid (300) 300
diagnosis (298) 298
orchiectomy (296) 296
docetaxel (293) 293
cancer therapies (291) 291
cancer patients (290) 290
breast-cancer (289) 289
surgery (289) 289
phase-iii trial (288) 288
trial (280) 280
radiation (278) 278
prostatic neoplasms - diagnosis (277) 277
prostatic neoplasms (273) 273
oncology, experimental (260) 260
female (251) 251
development and progression (250) 250
patient outcomes (249) 249
metastases (248) 248
bone-mineral density (239) 239
clinical trials (238) 238
double-blind (238) 238
hormonal-therapy (238) 238
progression (237) 237
review (232) 232
biochemical recurrence (231) 231
risk assessment (230) 230
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5304) 5304
German (152) 152
French (135) 135
Spanish (70) 70
Japanese (16) 16
Russian (7) 7
Chinese (5) 5
Polish (4) 4
Croatian (2) 2
Dutch (2) 2
Portuguese (2) 2
Turkish (2) 2
Belarusian (1) 1
Czech (1) 1
Hungarian (1) 1
Italian (1) 1
Korean (1) 1
Slovak (1) 1
Slovenian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 85, Issue 1, pp. 101 - 108
Purpose To assess the survival benefit of early vs late salvage hormonal therapy (HT), we performed a secondary analysis on patients who developed recurrence... 
Radiology | Hematology, Oncology and Palliative Medicine | PHASE-III TRIAL | ANDROGEN DEPRIVATION | RELAPSE | ONCOLOGY | DEFINITIVE RADIOTHERAPY | RANDOMIZED-TRIAL | ABLATION | RECURRENCE | SUPPRESSION | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | ANTIGEN | Neoplasm Recurrence, Local - radiotherapy | Prostatic Neoplasms - radiotherapy | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Male | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - pathology | Time Factors | Antineoplastic Agents, Hormonal - therapeutic use | Prostatic Neoplasms - blood | Neoplasm Recurrence, Local - blood | Prostatic Neoplasms - drug therapy | Adenocarcinoma - radiotherapy | Salvage Therapy - mortality | Prostatic Neoplasms - pathology | Drug Administration Schedule | Adenocarcinoma - blood | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Analysis of Variance | Neoadjuvant Therapy - methods | Survival Analysis | Aged | Salvage Therapy - methods | Adenocarcinoma - mortality | Medical research | Cancer patients | Care and treatment | Nuclear radiation | Patient outcomes | Adjuvant treatment | Medicine, Experimental | Radiotherapy | Prostate cancer | Cancer | PROSTATE | MULTIVARIATE ANALYSIS | PATIENTS | HEALTH HAZARDS | FAILURES | METASTASES | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | ANTIGENS | RADIOTHERAPY | HORMONES
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 6, pp. 747 - 756
Journal Article
Journal Article
Turk Onkoloji Dergisi, ISSN 1300-7467, 2015, Volume 30, Issue 1, pp. 25 - 33
Journal Article
European Urology, ISSN 0302-2838, 2016, Volume 71, Issue 4, pp. 630 - 642
Journal Article
CA: A Cancer Journal for Clinicians, ISSN 0007-9235, 07/2016, Volume 66, Issue 4, pp. 271 - 289
The number of cancer survivors continues to increase because of both advances in early detection and treatment and the aging and growth of the population. For... 
prevalence | survivorship | treatment patterns | statistics | LYMPH-NODE DISSECTION | ADJUVANT CHEMOTHERAPY | SELECTIVE BLADDER PRESERVATION | LONG-TERM SURVIVORS | BREAST-CONSERVING THERAPY | METASTATIC PROSTATE-CANCER | ANDROGEN-DEPRIVATION THERAPY | ONCOLOGY | COLORECTAL-CANCER | CARDIOVASCULAR-DISEASE | QUALITY-OF-LIFE | Uterine Neoplasms - therapy | United States - epidemiology | Prevalence | Humans | Middle Aged | Survivors - statistics & numerical data | Child, Preschool | National Cancer Institute (U.S.) | Infant | Male | Neoplasms - diagnosis | Incidence | Prostatic Neoplasms - therapy | Breast Neoplasms - therapy | American Cancer Society | Neoplasms - therapy | Skin Neoplasms - mortality | Aged, 80 and over | Uterine Neoplasms - mortality | Adult | Female | Registries | Child | Infant, Newborn | Colonic Neoplasms - therapy | Colonic Neoplasms - mortality | Skin Neoplasms - therapy | Risk Factors | Neoplasms - mortality | Survival Rate | Evidence-Based Medicine | Prostatic Neoplasms - mortality | Adolescent | Breast Neoplasms - mortality | Aged | Melanoma - therapy | Neoplasms - epidemiology | Melanoma - mortality | Care and treatment | Management | Primary health care | Analysis | Public health | Cancer | Survivor | Oncology | Family medical history | Disease management | Medical diagnosis | Medical statistics | Primary care
Journal Article